[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
[2] Alsina AE. Liver transplantation for hepatocellular carcinoma. Cancer Control. 2010;17:83-86.
[3] Ong HT, Tan PK, Wang SM, et al. The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target. Cancer Gene Ther. 2011; 18(6): 399-406.
[4] Ahn BC, Ronald JA, Kim YI, et al. Potent, tumor-specific gene expression in an orthotopic hepatoma rat model using a Survivin-targeted, amplifiable adenoviral vector. Gene Ther. 2011;18(6):606-612.
[5] Zeng ZJ, Xiang SG, Xue WW, et al. The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells. Biomed Pharmacother. 2014. [Epub ahead of print]
[6] Xiao X, Jin R, Li J, et al. The Antitumor Effect of Suicide Gene Therapy Using Bifidobacterium infantis-mediated Herpes Simplex Virus Thymidine Kinase/Ganciclovir in a Nude Mice Model of Renal Cell Carcinoma. Urology. 2014;84(4):982. e15-20.
[7] Vile RG, Catleden S, Marshall J, et al. Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression. Cancer. 1997;71(2):267-274.
[8] Beltinger C,Fulda S,Kammertoens T, et al. Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. Cancer Res. 2000;60(12):3212-3127.
[9] Yu BF, Wu J, Zhang Y, et al. Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma.Cancer Gene Ther. 2013;20(5):290-297.
[10] Beltinger C, Fulda S, Kammertoens T, et al. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis in-volves ligand-independent death receptor aggregation and activation of caspases.Proc Natl Acad Sci USA. 1999; 96(15): 8699-8704.
[11] Zhou XL, Shi YL, Li X. Inhibitory effects of the ultrasound-targeted microbubble destruction-mediated herpes simplex virus-thymidine kinase/ganciclovir system on ovarian cancer in mice. Exp Ther Med. 2014;8(4):1159-1163.
[12] Zhu R, Chen D, Lin D, et al. Adenovirus vector-mediated herpes simplex virus-thymidine kinase gene/ganciclovir system exhibits anti-tumor effects in an orthotopic hepatocellular carcinoma model. Pharmazie. 2014;69(7): 547-552.
[13] 查锡良.生物化学[M]. 7版.北京:人民卫生出版社,2008: 153-154.
[14] Mahley RW, Huang Y, Weisgraber KH. Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest. 2006;116(5):1226-1229.
[15] 程牛亮.生物化学[M].1版.北京:高等教育出版社,2005: 109.
[16] 秦琴,莱智勇,高然朋,等.载脂蛋白ApoE修饰脂质体对肝癌细胞的靶向转染[J].中华实验外科杂志,2014,31(8):1709-1711.
[17] Lai Z, Qin Q, Yu B, et al. Construction of plasmid vector pAFP-HSVtk-IRES2-EGFP and its effect on the cytotoxicity of ganciclovir to hepatocellular carcinoma. Chin Med J (Engl). 2014;127(12):2337-2341.
[18] Raki M, Hakkarainen T, Bauerschmitz GJ, et al. Utility of TK/GCV in the context of highly effective oncolysis mediated by a serotype 3 receptor targeted oncolytic adenovirus. Gene Ther. 2007;14(19):1380-1388.
[19] Inoue H, Shiraki K, Murata K, et al. Adenoviral-mediated transfer of p53 gene enhances TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Int J Mol Med. 2004; 14(2):271-275.
[20] Sheng S, Zheng J, Cui S, et al. Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene. Anticancer Drugs. 2014. [Epub ahead of print]
[21] Sangro B, Mazzolini G, Ruiz J, et al. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors. J Clin Oncol. 2004; 22(8):1389-1397.
[22] Bai FL, Yu YH, Tian H, et al. Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy. Cancer Biol Ther. 2014;15(9):1226-1238.
[23] Maeda S, Wada H, Naito Y, et al. Interferon-α Acts on the S/G2/M Phases to Induce Apoptosis in the G1 Phase of an IFNAR2-expressing Hepatocellular Carcinoma Cell Line. J Biol Chem. 2014;289(34):23786-23795.
[24] Asklund T, Appelskog IB, Ammerpohl O, et al. Gap junction-mediated bystander effect in primary cultures of human malignant gliomas with recombinant expression of the HSVtk gene. Exp Cell Res. 2003;284(2): 185-195.
[25] Chiu CC, Kang YL, Yang TH, et al. Ectopic expression of herpes simplex virus-thymidine kinase gene in human non-small cell lung cancer cells conferred caspase-activated apoptosis sensitized by ganciclovir. Int J Cancer. 2002;102(4): 328-333.
[26] Kurozumi K, Tamiya T, Ono Y, et al. Apoptosis induction with 5-fluorocytosine/cytosine deaminase gene therapy for human malignant glioma cells mediated by adenovirus. J Neurooncol. 2004;66(1-2):117-127.
[27] van der Linden RR, Haagmans BL, Mongiat-Artus P, et al. Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancer. Eur Urol. 2005;48(1):153-161.
[28] Agard C, Ligeza C, Dupas B, et al. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis. Cancer Gene Ther. 2001;8(2):128-136.
[29] Gérolami R, Uch R, Bréchot C, et al. Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact. Cancer Gene Ther. 2003;10(9):649-660.
[30] Park JW, Hong K, Kirpotin DB, et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res. 2002;8(4): 1172-1181. |